Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

vsm geneesmiddelen b.v. berenkoog 35 1822 bh alkmaar - ledum palustre ø ; rhus toxicodendron ø ; symphytum officinale ø - crème - , , , , , , , , , , , , , , , , , , , , , , , - datum verstrekking handelsvergunning:03 juni 2002

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - cinnarizine 75 mg - capsule, hard - 75 mg - cinnarizine 75 mg - cinnarizine

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatris healthcare sa-nv - fenprocoumon 3 mg - tablet - 3 mg - fenprocoumon 3 mg - phenprocoumon

Europese Unie - Nederlands - EMA (European Medicines Agency)

vertex pharmaceuticals (ireland) limited - ivacaftor - taaislijmziekte - andere producten van het ademhalingssysteem - kalydeco tablets are indicated:as monotherapy for the treatment of adults, adolescents, and children aged 6 years and older and weighing 25 kg or more with cystic fibrosis (cf) who have an r117h cftr mutation or one of the following gating (class iii) mutations in the cystic fibrosis transmembrane conductance regulator (cftr) gene: g551d, g1244e, g1349d, g178r, g551s, s1251n, s1255p, s549n or s549r (see sections 4. 4 en 5. in a combination regimen with tezacaftor/ivacaftor tablets for the treatment of adults, adolescents, and children aged 6 years and older with cystic fibrosis (cf) who are homozygous for the f508del mutation or who are heterozygous for the f508del mutation and have one of the following mutations in the cftr gene: p67l, r117c, l206w, r352q, a455e, d579g, 711+3a→g, s945l, s977f, r1070w, d1152h, 2789+5g→a, 3272 26a→g, and 3849+10kbc→t. in a combination regimen with ivacaftor/tezacaftor/elexacaftor tablets for the treatment of adults, adolescents, and children aged 6 years and older with cystic fibrosis (cf) who have at least one f508del mutation in the cftr gene (see section 5. kalydeco granules are indicated for the treatment of infants aged at least 4 months, toddlers and children weighing 5 kg to less than 25 kg with cystic fibrosis (cf) who have an r117h cftr mutation or one of the following gating (class iii) mutations in the cftr gene: g551d, g1244e, g1349d, g178r, g551s, s1251n, s1255p, s549n or s549r (see sections 4. 4 en 5. in a combination regimen with ivacaftor/tezacaftor/elexacaftor for the treatment of cystic fibrosis (cf) in paediatric patients aged 2 to less than 6 years who have at least one f508del mutation in the cftr gene.

Europese Unie - Nederlands - EMA (European Medicines Agency)

vertex pharmaceuticals (ireland) limited - lumacaftor, ivacaftor - taaislijmziekte - andere producten van het ademhalingssysteem - orkambi tabletten zijn geïndiceerd voor de behandeling van cystic fibrosis (cf) patiënten in de leeftijd van 6 jaar en ouder, die homozygoot is voor de f508del mutatie in het cftr-gen. orkambi granules are indicated for the treatment of cystic fibrosis (cf) in children aged 1 year and older who are homozygous for the f508del mutation in the cftr gene.

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

ceva sante animale s.a. - selegilinehydrochloride; selegiline - filmomhulde tablet - selegilinehydrochloride 20 mg/stuk; selegiline 16,74 mg/stuk, - selegiline - honden

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

ceva sante animale s.a. - selegilinehydrochloride; selegiline - filmomhulde tablet - selegilinehydrochloride 10 mg/stuk; selegiline 8,37 mg/stuk, - selegiline - honden

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

ceva sante animale s.a. - selegilinehydrochloride; selegiline - filmomhulde tablet - selegilinehydrochloride 4 mg/stuk; selegiline 3,35 mg/stuk, - selegiline - honden

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

brillpharma (ireland) limited iniscarra, main street rathcoole (ierland) - carbidopa 1-water 10,8 mg/stuk samenstelling overeenkomend met ; carbidopa 0-water 10 mg/stuk ; levodopa 100 mg/stuk - tablet - cellulose, microkristallijn (e 460(i)) ; crospovidon (e 1202) ; indigokarmijn aluminiumlak (e 132) ; magnesiumstearaat (e 470b) ; zetmeel, gepregelatineerd, cellulose, microkristallijn (e 460) ; crospovidon (e 1202) ; indigokarmijn aluminiumlak (e 132) ; magnesiumstearaat (e 470b) ; zetmeel, gepregelatineerd, - levodopa and decarboxylase inhibitor